Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Join | Sign in
Home>Products>Product Directory>Biosimilars/Biologics
  Product Directory
More information
Biosimilars/Biologics

Boehringer Ingelheim RCV GmbH & Co KG
Boehringer Ingelheim
Request a quote
More information
Broad Microbial Contamination Detection on one platform with results within 8 hours
Abbott Laboratories – Ibis Biosciences Business Unit
Request a quote
More information
Catalent Pharma Solutions
Catalent Pharma Solutions
Request a quote
More information
Covance, Inc.
Covance - Service Directory
Request a quote
More information
deGlycIT MaxiSpin, Deglycosylates 10-100 mg
Genovis AB
Request a quote
More information
deGlycIT MicroSpin, Deglycosylates 10 x 0.5 mg
Genovis AB
Request a quote
More information
deGlycIT MicroSpin, Deglycosylates 2 x 0.5 mg
Genovis AB
Request a quote
More information
deGlycIT MicroSpin, Deglycosylates 5 x 0.5 mg
Genovis AB
Request a quote
More information
deGlycIT MidiSpin, Deglycosylates 1-10 mg
Genovis AB
Request a quote
More information
FabRICATOR, 2000 Units
Genovis AB
Request a quote
More information
<< 1 2 3 >>
Showing Results 1 - 10 of 26
Scientific News
Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.
Study Announces a Durable Vaccine for Ebola
Researchers from Plymouth University have led team which has developed a durable vaccine for Ebola together with a disseminating vaccine strategy.
New Hopes For Rheumatic Fever Vaccination
Progress is made by a new initiative funded by CANVAS.
A Vaccine Against Placental Malaria Made with ExpreS2
ExpreS2ion Biotechnologies’ protein expression technology is ready to start human tests in Germany and Benin.
Strengthening the Immune System’s Fight Against Brain Cancer
NIH-funded research suggests novel way to improve vaccine efficacy in brain tumors.
NIH-Sponsored HIV Vaccine Trial Launches In South Africa
Early-stage trial aims to build on RV144 results.
New Class of Antibodies Raises Hope of Dengue Fever Vaccine
Scientists have discovered a new class of human antibodies against the dengue fever virus, which could be exploited to develop a vaccine.
Ebola Vaccine Trial Opens in Liberia
Study led by Liberia-NIH partnership will test two experimental vaccines.
Beating The Clock: New Treatment For Rabies Developed
University of Georgia researchers have developed a new treatment for rabies.
Utilizing Fast HPLC Screening Methods for the Detection of Steroids
Analysis of steroids improved by choosing the optimal HPLC column for the separation.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters